T
Thomas J. Byrne
Researcher at Mayo Clinic
Publications - 45
Citations - 1743
Thomas J. Byrne is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Liver transplantation & Transplantation. The author has an hindex of 19, co-authored 44 publications receiving 1591 citations.
Papers
More filters
Journal ArticleDOI
Six‐minute walk distance predicts mortality in liver transplant candidates
Elizabeth J. Carey,D. Eric Steidley,Bashar Aqel,Thomas J. Byrne,Kristin L. Mekeel,Jorge Rakela,Hugo E. Vargas,David D. Douglas +7 more
TL;DR: The 6MWD is significantly reduced in patients awaiting LT and is inversely correlated with the native MELD score, which is commonly used to predict mortality in patients with cardiac and pulmonary diseases.
Journal ArticleDOI
Liver transplantation for hepatocellular carcinoma: the MELD impact.
Pratima Sharma,Vijayan Balan,Jose L. Hernandez,Ann M. Harper,Erick B. Edwards,Hector Rodriguez-Luna,Thomas J. Byrne,Hugo E. Vargas,David C. Mulligan,Jorge Rakela,Russell H. Wiesner +10 more
TL;DR: The new allocation policy of the United Network of Organ Sharing based on the model for end‐stage liver disease (MELD) gives candidates with stage T1 or stage T2 hepatocellular carcinoma (HCC) a priority MELD score beyond their degree of hepatic decompensation, leading to an increased incidence rate of DDLT in HCC candidates.
Journal ArticleDOI
Endoscopic treatment of anastomotic biliary strictures after living donor liver transplantation: outcomes after maximal stent therapy.
Ting Hui Hsieh,Kristin L. Mekeel,Michael D. Crowell,Cuong C. Nguyen,Ananya Das,Bashar Aqel,Elizabeth J. Carey,Thomas J. Byrne,Hugo E. Vargas,David D. Douglas,David C. Mulligan,M. Edwyn Harrison +11 more
TL;DR: In this article, an endoscopic retrograde cholangiography with balloon dilation and maximal stent placement was used to resolve biliary strictures after living-donor liver transplantation.
Journal ArticleDOI
Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation.
Kristina T. Werner,Shawna Sando,Elizabeth J. Carey,Hugo E. Vargas,Thomas J. Byrne,David D. Douglas,M. E. Harrison,Jorge Rakela,Bashar Aqel +8 more
TL;DR: PVT is frequently seen in patients with end stage liver disease with prevalence of 13 %.
Journal ArticleDOI
Relationship between sarcopenia, six-minute walk distance and health-related quality of life in liver transplant candidates.
Anitha Yadav,Yu Hui H. Chang,Sarah Carpenter,Alvin C. Silva,Jorge Rakela,Bashar Aqel,Thomas J. Byrne,David D. Douglas,Hugo E. Vargas,Elizabeth J. Carey +9 more
TL;DR: In patients with ESLD awaiting LT, 6MWD appears to be a more useful prognostic indicator than the presence of sarcopenia, and also failed to correlate with either functional capacity or HRQOL in LT candidates.